Promising Experimental Therapy Offers Hope for Celiac Disease Treatment

Recent groundbreaking experiments have demonstrated a promising approach that could lead to the world's first effective treatment for celiac disease, a severe autoimmune disorder affecting millions globally. Researchers from Switzerland, collaborating with teams from the University of California and the Norwegian Celiac Disease Research Center, have developed a novel cell-based therapy that targets the immune system's malfunction responsible for tissue damage in the small intestine. This innovative strategy, inspired by advanced cancer immunotherapies like CAR T cells, modifies immune cells to suppress the hyperactive response to gluten, the protein in wheat, barley, and rye that triggers celiac symptoms.

Celiac disease affects about 1% of the world's population and is characterized by an autoimmune response that leads to intestinal inflammation, malnutrition, bone loss, anemia, and an increased risk of gastrointestinal cancers. Patients must adhere to a strict gluten-free diet, which, despite being effective for many, can cause social and nutritional challenges.

The research team engineered specific regulatory T cells (Tregs) and effector T cells that can modulate the immune response to gluten. In animal models, these engineered Tregs successfully prevented the migration of effector T cells to the gut and suppressed their proliferation upon gluten exposure. This proof-of-concept suggests that cell therapy might restore gluten tolerance, significantly improving the quality of life for those with celiac disease.

Lead researcher Dr. Raphaël Porret emphasizes that although further studies are necessary to evaluate the efficacy in active disease states, these early results mark a considerable step toward developing targeted treatments that could potentially eliminate the need for lifelong gluten avoidance. The innovative approach opens new avenues for immune modulation therapies in autoimmune diseases.

This research was published in Science Translational Medicine and indicates a future where celiac disease could be managed with precision immune cell therapies, moving beyond diet restrictions to a strategic immune intervention.

[Source]{https://medicalxpress.com/news/2025-05-positive-proof-concept-world-treatment.html}